CN114807359B - 一种用于检测基因突变的封闭型荧光探针 - Google Patents
一种用于检测基因突变的封闭型荧光探针 Download PDFInfo
- Publication number
- CN114807359B CN114807359B CN202210720247.5A CN202210720247A CN114807359B CN 114807359 B CN114807359 B CN 114807359B CN 202210720247 A CN202210720247 A CN 202210720247A CN 114807359 B CN114807359 B CN 114807359B
- Authority
- CN
- China
- Prior art keywords
- probe
- fluorescent probe
- fluorescent
- blocked
- closed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 99
- 206010064571 Gene mutation Diseases 0.000 title claims abstract description 32
- 239000000523 sample Substances 0.000 claims abstract description 86
- 230000003321 amplification Effects 0.000 claims abstract description 48
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 48
- 230000035772 mutation Effects 0.000 claims abstract description 39
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 34
- 238000011529 RT qPCR Methods 0.000 claims abstract description 21
- 230000000295 complement effect Effects 0.000 claims abstract description 15
- 125000006853 reporter group Chemical group 0.000 claims abstract description 15
- 238000010791 quenching Methods 0.000 claims abstract description 13
- 230000000171 quenching effect Effects 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 36
- 239000002773 nucleotide Substances 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 239000013642 negative control Substances 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 10
- 108090000790 Enzymes Proteins 0.000 claims description 10
- 108010006785 Taq Polymerase Proteins 0.000 claims description 9
- -1 BHQ1 Chemical compound 0.000 claims description 6
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 6
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 5
- 239000013641 positive control Substances 0.000 claims description 4
- 239000000872 buffer Substances 0.000 claims description 3
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 2
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 38
- 230000000903 blocking effect Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 16
- 230000000694 effects Effects 0.000 description 13
- 238000013461 design Methods 0.000 description 10
- 239000007853 buffer solution Substances 0.000 description 9
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 238000011144 upstream manufacturing Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 101150104466 NOCT gene Proteins 0.000 description 5
- 150000007523 nucleic acids Chemical class 0.000 description 5
- 102200006538 rs121913530 Human genes 0.000 description 5
- 239000012085 test solution Substances 0.000 description 5
- 238000011109 contamination Methods 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 108020004707 nucleic acids Proteins 0.000 description 4
- 102000039446 nucleic acids Human genes 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036438 mutation frequency Effects 0.000 description 3
- 238000007481 next generation sequencing Methods 0.000 description 3
- 238000012257 pre-denaturation Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 2
- 101150040459 RAS gene Proteins 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 101150047500 TERT gene Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- JJWKPURADFRFRB-UHFFFAOYSA-N carbonyl sulfide Chemical compound O=C=S JJWKPURADFRFRB-UHFFFAOYSA-N 0.000 description 2
- 235000019993 champagne Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910001425 magnesium ion Inorganic materials 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102100030708 GTPase KRas Human genes 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210720247.5A CN114807359B (zh) | 2022-06-24 | 2022-06-24 | 一种用于检测基因突变的封闭型荧光探针 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210720247.5A CN114807359B (zh) | 2022-06-24 | 2022-06-24 | 一种用于检测基因突变的封闭型荧光探针 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114807359A CN114807359A (zh) | 2022-07-29 |
CN114807359B true CN114807359B (zh) | 2022-09-30 |
Family
ID=82521375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210720247.5A Active CN114807359B (zh) | 2022-06-24 | 2022-06-24 | 一种用于检测基因突变的封闭型荧光探针 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114807359B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018059525A1 (zh) * | 2016-09-30 | 2018-04-05 | 苏州新海生物科技股份有限公司 | 一种检测目标核酸序列变异体的组合物和方法及试剂盒 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101312241B1 (ko) * | 2010-04-27 | 2013-09-27 | 사회복지법인 삼성생명공익재단 | 증폭억제시발체를 이용하는 유전자 돌연변이 검출 방법 |
-
2022
- 2022-06-24 CN CN202210720247.5A patent/CN114807359B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018059525A1 (zh) * | 2016-09-30 | 2018-04-05 | 苏州新海生物科技股份有限公司 | 一种检测目标核酸序列变异体的组合物和方法及试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN114807359A (zh) | 2022-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8679788B2 (en) | Methods for the detection of nucleic acid differences | |
EP2314680B1 (en) | Method for amplification of target nucleic acid sequence, method for detection of mutation by using the method, and reagents for use in the methods | |
JP2001057892A (ja) | 核酸配列変異を検出するための方法とオリゴヌクレオチド | |
EP2412718B1 (en) | Loop-shaped primer employed in nucleic acid amplification and the use thereof | |
CN113308519B (zh) | 用于检测单碱基突变位点的引物和探针及检测方法 | |
US20130084568A1 (en) | Probe, and polymorphism detection method using the same | |
CN111020031A (zh) | 序列特异性阻断剂结合特定pcr程序检测肿瘤基因突变的方法 | |
CN114085903B (zh) | 检测线粒体3243a>g突变的引物对探针组合产品及其试剂盒与检测方法 | |
CN117070607B (zh) | 一种检测人脊髓性肌萎缩症smn1和smn2基因拷贝数的荧光定量pcr试剂盒 | |
CN112941210A (zh) | 结核分枝杆菌利福平和异烟肼耐药突变检测试剂盒及方法 | |
CN112029837A (zh) | 一种基于锁核酸修饰的重组酶介导的等温扩增法检测snp位点的试剂盒及其检测方法 | |
CN110791577A (zh) | 一种检测结核分枝杆菌异烟肼耐药突变基因的试剂盒及方法 | |
CN110846408A (zh) | 用于检测ttn基因突变的引物组合及其应用 | |
CN109321651A (zh) | 一种检测人cyp2d6基因多态性的组合物、试剂盒、样品处理方法和应用 | |
US11414698B2 (en) | Method of quantifying mutant allele burden of target gene | |
CN114807359B (zh) | 一种用于检测基因突变的封闭型荧光探针 | |
CN116004775A (zh) | 一种人运动神经元拷贝数定量的引物探针组合物、试剂盒及方法 | |
US20110236892A1 (en) | Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay | |
EP3350349A2 (en) | Reagents and methods for analysis of hiv | |
CN113215228A (zh) | 脆性x综合征fmr1基因检测引物、试剂盒及其应用 | |
CN117344008B (zh) | 基于2-ΔΔCt法检测SMN1基因拷贝数的试剂盒 | |
Kim et al. | Fluorometric detection of low-abundance EGFR exon 19 deletion mutation using tandem gene amplification | |
CN114182003B (zh) | 用于cyp3a5多态性位点基因分型检测的试剂盒及其检测方法 | |
CN116814774A (zh) | 一组检测药物性耳聋1555A/G基因分型的TaqMan-ARMS-PCR引物探针设计及其应用 | |
CN114438181A (zh) | 一种减少pcr反应中引物二聚体扩增的试剂和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220908 Address after: 201100 5th floor, building 2, No. 3632, Zhaolou Road, Minhang District, Shanghai Applicant after: SHANGHAI RUIJING BIOTECHNOLOGY Co.,Ltd. Address before: 201318 floor 1, building 2, No. 168178 Banxia Road, Pudong New Area, Shanghai Applicant before: SHANGHAI PENGGGUAN BIOLOGICAL MEDICEINE TEC. CO.,LTD. Applicant before: SHANGHAI RUIJING BIOTECHNOLOGY Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A closed fluorescent probe for detecting gene mutations Effective date of registration: 20231220 Granted publication date: 20220930 Pledgee: Industrial Bank Co.,Ltd. Shanghai Minhang sub branch Pledgor: SHANGHAI RUIJING BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023310000893 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |